Tag: clinical trials

Traceability Across Safety, EDC, Labs and Imaging Repositories

Posted on By digi

Traceability Across Safety, EDC, Labs and Imaging Repositories In the landscape of clinical trials, ensuring data traceability is essential for maintaining integrity, compliance, and safety. This comprehensive guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a step-by-step tutorial on how to ensure traceability across various data sources, including safety reports,…

Read More “Traceability Across Safety, EDC, Labs and Imaging Repositories” »

Audit Trails & Data Traceability

Training Study Teams on Practical RCA Using Real Case Studies

Posted on By digi

Training Study Teams on Practical RCA Using Real Case Studies Root Cause Analysis (RCA) is an essential process in clinical research that helps identify the underlying reasons for issues that impact study outcomes and regulatory compliance. Effective RCA can significantly enhance the quality of clinical trials, leading to improved patient safety and data integrity. This…

Read More “Training Study Teams on Practical RCA Using Real Case Studies” »

Root Cause Analysis (5 Whys, Fishbone)

Managing Underperforming Sites: Interventions, Remediation and Closure

Posted on By digi

Managing Underperforming Sites: Interventions, Remediation and Closure Managing Underperforming Sites: Interventions, Remediation and Closure Clinical trials are particularly complex endeavors, requiring precise coordination and management to ensure the success of new treatment protocols. The ability to manage underperforming sites effectively can be crucial to a trial’s integrity and overall success. This article serves as a…

Read More “Managing Underperforming Sites: Interventions, Remediation and Closure” »

Site KPIs & Performance Management

Benchmarking Sites Across Studies, Countries and Therapeutic Areas

Posted on By digi

Benchmarking Sites Across Studies, Countries and Therapeutic Areas Benchmarking Sites Across Studies, Countries and Therapeutic Areas Benchmarking sites in clinical trials is essential for ensuring optimal performance and compliance across various studies, countries, and therapeutic areas. This guide provides a thorough overview of the methodological framework for effectively evaluating and comparing clinical trial sites, with…

Read More “Benchmarking Sites Across Studies, Countries and Therapeutic Areas” »

Site KPIs & Performance Management

Configuring Audit Trails: What to Turn On, Off or Archive

Posted on By digi

Configuring Audit Trails: What to Turn On, Off or Archive Configuring Audit Trails: What to Turn On, Off or Archive In contemporary clinical research, ensuring data integrity and compliance with regulatory standards is pivotal. Developing an acute understanding of audit trails within CTMS systems for clinical trials ensures that clinical operations teams can document procedural…

Read More “Configuring Audit Trails: What to Turn On, Off or Archive” »

Audit Trails & Data Traceability

Using Audit Trail Reviews in Risk-Based Monitoring and Data Quality Checks

Posted on By digi

Using Audit Trail Reviews in Risk-Based Monitoring and Data Quality Checks Clinical trial data integrity is a primary concern among clinical research organization companies as well as regulatory authorities. The conventional monitoring approaches are increasingly being challenged by the emergence of technology and the evolving complexity of clinical trials, especially in fields like biosimilar clinical…

Read More “Using Audit Trail Reviews in Risk-Based Monitoring and Data Quality Checks” »

Audit Trails & Data Traceability

Linking RCA to Risk Assessment, QTLs and KRIs in Clinical Programs

Posted on By digi

Linking RCA to Risk Assessment, QTLs and KRIs in Clinical Programs Linking RCA to Risk Assessment, QTLs and KRIs in Clinical Programs In the complex and highly regulated environment of clinical trials, effective management of quality and risk is paramount. This article provides a detailed, step-by-step tutorial on linking Root Cause Analysis (RCA) to Risk…

Read More “Linking RCA to Risk Assessment, QTLs and KRIs in Clinical Programs” »

Root Cause Analysis (5 Whys, Fishbone)

Using KPIs to Inform Site Support, Corrective Action and Study Decisions

Posted on By digi

Using KPIs to Inform Site Support, Corrective Action and Study Decisions Using KPIs to Inform Site Support, Corrective Action and Study Decisions In clinical research trials, the performance of clinical trial sites is paramount for the successful execution of a study. Key Performance Indicators (KPIs) provide an essential framework for evaluating and enhancing site performance,…

Read More “Using KPIs to Inform Site Support, Corrective Action and Study Decisions” »

Site KPIs & Performance Management

Rewarding High-Performing Sites Without Creating Perverse Incentives

Posted on By digi

Rewarding High-Performing Sites Without Creating Perverse Incentives Rewarding High-Performing Sites Without Creating Perverse Incentives In the realm of translational clinical research, effective management of clinical trial sites is paramount to the success of studies. Rewarding high-performing sites can enhance motivation and efficacy but needs to be balanced delicately to avoid perverse incentives. This guide outlines…

Read More “Rewarding High-Performing Sites Without Creating Perverse Incentives” »

Site KPIs & Performance Management

User Access Management and Segregation of Duties for GCP Systems

Posted on By digi

User Access Management and Segregation of Duties for GCP Systems User Access Management and Segregation of Duties for GCP Systems User Access Management and Segregation of Duties (SoD) represent crucial elements of Good Clinical Practice (GCP) compliance in clinical trials, including those focused on ankylosing spondylitis clinical trials. Ensuring integrity and traceability of data through…

Read More “User Access Management and Segregation of Duties for GCP Systems” »

Audit Trails & Data Traceability